MAZE — MAZE THERAPEUTICS, INC.

Ownership history in TRV GP V, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which TRV GP V, LLC reported a position in MAZE THERAPEUTICS, INC. (MAZE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
9.18% (2025 Q4)
Avg. % of fund
7.89%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 950,800 — 0% 9.18% $39.4M $41.43
2025 Q3 UNCHANGED 950,800 — 0% 6.97% $24.7M $25.93
2025 Q2 UNCHANGED 950,800 — 0% 7.04% $11.7M $12.27
2025 Q1 INITIATED 950,800 — — 8.37% $10.5M $11.01
% of Fund (quarterly)    MAZE price (monthly, adj. close)

Other funds also holding MAZE

As of 2025 Q4 — sorted by position size

TRV GP IV, LLC 3Y 72.65% Matrix Capital Management Company, LP 3Y 7Y 34.52% ARCH Venture Management, LLC 3Y 7Y 26.19% General Catalyst Group Management, LLC 3Y 7Y 19.35% Foresite Capital Management IV, LLC 3Y 7Y 9.43% WASHINGTON UNIVERSITY 3Y 5.88% Frazier Life Sciences Management, L.P. 3Y 5.08% a16z Capital Management, L.L.C. 4.46% VR Adviser, LLC 3Y 3.17% Deep Track Capital, LP 3Y 3.14%
← Back to TRV GP V, LLC Holdings